Target intelligence / Profile preview

Plasma filtration with selective adsorbent columns

Molecular classification
Other
01

Overview

Selective plasma filtration with adsorbent columns refers to a class of extracorporeal blood purification procedures in which plasma is separated from whole blood and passed through columns containing selective adsorbent materials. These columns use physical and chemical properties (such as pore size, affinity ligands, or hydrophobic/ionic interactions) to specifically remove unwanted substances—such as autoantibodies, cytokines, or endotoxins—while returning the bulk of desirable plasma proteins to the patient[1][2][3][4]. Techniques include "coupled plasma filtration and adsorption" (CPFA) and immunoadsorption. These therapies are primarily used as adjuncts in the treatment of systemic inflammatory conditions (such as sepsis or fulminant hepatic failure), with the aim of lowering circulating levels of inflammatory mediators, immune complexes, or toxins. This approach does not target a specific molecule or receptor, but operates by physical removal mechanisms. Selective adsorbent columns may employ materials such as cellulose diacetate membranes or affinity beads[1][2].

Other names
Selective plasma filtrationSelective plasma exchangePlasma adsorption therapyCoupled plasma filtration adsorption
02

Mechanism of action

Blood or plasma is separated and passed through selective adsorbent columns to remove targeted pathogenic substances by filtration or adsorption[1][2][3][4]

03

Biological functions

Removal of pathogenic plasma factorsDetoxificationSupportive therapy in fulminant hepatic failure, sepsis, and autoimmune disease
04

Disease associations

SepsisAcute liver failureAutoimmune diseasesSystemic inflammatory response syndrome (SIRS)
05

Safety considerations

Loss of beneficial plasma proteinsPotential for immune suppressionNeed for vascular accessVariability in removal of therapeutic substancesProtein allergy to substitution fluids (minimized with some techniques)
06

Biomarkers

Cytokines (e.g., TNF-α)Endotoxins (e.g., LPS)Immunoglobulins (e.g., IgG, IgM)ProcalcitoninEndotoxin activity assay (EAA)

Beyond the preview

Go deeper on Plasma filtration with selective adsorbent columns.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasma filtration with selective adsorbent columns.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call